Perceptions of masculinity and body image in men with prostate cancer: the role of exercise
The goal of this study was to explore the association between levels of exercise and patterns of masculinity, body image, and quality of life in men undergoing diverse treatment protocols for prostate cancer.
Fifty men with prostate cancer (aged 42–86) completed self-report measures. Self-reported measures included the following: the Godin Leisure Time Exercise Questionnaire (GLTEQ), Masculine Self-esteem Scale (MSES), Personal Attributes Questionnaire (PAQ), Body Image Scale (BIS), and the Functional Assessment of Cancer Therapy–Prostate (FACT-P). Masculinity, body image, and quality of life scores were compared between men obtaining recommended levels of exercise (aerobic or resistance) and those not obtaining recommended level of exercise. Secondary outcomes included the association between masculinity, body image, and quality of life scores as they relate to exercise levels.
There were significantly higher scores of masculinity (p < 0.01), physical well-being (p < 0.05), prostate cancer specific well-being (p < 0.05), and overall quality of life (p < 0.05) in those obtaining at least 150 min of moderate to vigorous aerobic exercise. In the 48% of men who had never received androgen deprivation therapy, significantly higher levels of masculinity, body image, and quality of life were observed in those meeting aerobic guidelines.
Whether treatment includes androgen deprivation or not, men who participate in higher levels of aerobic exercises report higher levels of masculinity, improved body image, and quality of life than those who are inactive. Future longitudinal research is required evaluating exercise level and its effect on masculinity and body image.
KeywordsBody image Masculinity Movement Prostatic neoplasms Oncology Self-concept
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of The University of Calgary Health Research Ethics Board of Alberta (HREBA)–Cancer Committee (HREBA.CC-16-0625_REN1), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 3.Statistics Canada (2017) Population and demography. Government of Canada. Retrieved 20 September 2017 from https://www.statcan.gc.ca
- 7.McGinty HL, Phillips KM, Jim HS, Cessna JM, Asvat Y, Cases MG, Small BJ, Jacobsen PB (2014) Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis. Support Care Cancer 22(8):2271–2280. https://doi.org/10.1007/s00520-014-2285-1 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Cormie P, Chambers SK, Newton RU, Gardiner RA, Spry N, Taaffe DR, Joseph D, Hamid MA, Chong P, Hughes D, Hamilton K, Galvao DA (2014) Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies. BMC Cancer 14(199):1–9. https://doi.org/10.1186/1471-2407-14-199. Google Scholar
- 15.Culos-Reed SN, Robinson JW, Lau H, Stephenson L, Keats M, Norris S, Kline G, Faris P (2010) Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Support Care Cancer 18(5):591–599. https://doi.org/10.1007/s00520-009-0694-3 CrossRefPubMedGoogle Scholar
- 16.Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU (2010) Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 28(2):340–347. https://doi.org/10.1200/JCO.2009.23.2488 CrossRefPubMedGoogle Scholar
- 18.Cormie P, Galvao DA, Spry N, Joseph D, Chee R, Taaffe DR, Chambers SK, Newton RU (2015) Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int 115(2):256–266. https://doi.org/10.1111/bju.12646 CrossRefPubMedGoogle Scholar
- 19.Cormie P, Newton RU, Taaffe DR, Spry N, Joseph D, Akhlil Hamid M, Galvao DA (2013) Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis 16(2):170–175. https://doi.org/10.1038/pcan.2012.52 CrossRefPubMedGoogle Scholar
- 21.Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, Malone SC, Wells GA, Scott CG, Slovinec D'Angelo ME (2009) Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 27(3):344–351. https://doi.org/10.1200/JCO.2007.15.4963 CrossRefPubMedGoogle Scholar
- 30.Bruun DM, Krustrup P, Hornstrup T, Uth J, Brasso K, Rorth M, Christensen JF, Midtgaard J (2014) "all boys and men can play football": a qualitative investigation of recreational football in prostate cancer patients. Scand J Med Sci Sports 24(Suppl 1):113–121. https://doi.org/10.1111/sms.12193 CrossRefPubMedGoogle Scholar
- 34.Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426. https://doi.org/10.1249/MSS.0b013e3181e0c112 CrossRefPubMedGoogle Scholar
- 38.Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Barnicle M, Stewart I, McHale M, Bonomi P, Kaplan E, Taylor S, Thomas C, Harris J (1993) The functional assessment of Cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579. https://doi.org/10.1200/JCO.19188.8.131.520 CrossRefPubMedGoogle Scholar
- 39.Cella D, Nichol MB, Eton D, Nelson JB, Mulani P (2009) Estimating clinically meaningful changes for the functional assessment of Cancer therapy--prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health 12(1):124–129. https://doi.org/10.1111/j.1524-4733.2008.00409.x CrossRefPubMedGoogle Scholar
- 42.Keilani M, Hasenoehrl T, Baumann L, Ristl R, Schwarz M, Marhold M, Sedghi Komandj T, Crevenna R (2017) Effects of resistance exercise in prostate cancer patients: a meta-analysis. Support Care Cancer 25(9):2953–2968. https://doi.org/10.1007/s00520-017-3771-z CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Keogh JW, Patel A, MacLeod RD, Masters J (2013) Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: possible influence of androgen deprivation therapy. Psychooncology 22(12):2869–2875. https://doi.org/10.1002/pon.3363 CrossRefPubMedGoogle Scholar